Presentation TCT 2018 WELLTH: Improved Adherence with Behavioral Economics Presenter: Sanjeev Bhavnani, Issam D. Moussa, Matthew Loper September 21, 2018
Presentation TCT 2018 SnapMD: Virtual Care Management Presenter: Sanjeev Bhavnani, Issam D. Moussa, David J Skibinski September 21, 2018
Presentation TCT 2018 Using an AI-Powered Cognitive Engine to Drive Clinical & Financial Outcomes Presenter: Sanjeev Bhavnani, Issam D. Moussa, Gautam Sivakumar September 21, 2018
Presentation TCT 2018 Featured Lecture #2: Democratizing Clinical Excellence: Combining Digitized Patient Data and Guideline-Directed Best Practice Presenter: Sanjeev Bhavnani, Issam D. Moussa, Lonny Reisman September 21, 2018
Presentation SCAD 2018 The Vancouver SCAD Cardiac Rehab Program Presenter: Taira Birnie September 07, 2018
Presentation The Structural Heart Disease Summit 2018 Snapshot #3: Novel Tips and Tricks to Simplify TAVI Presenter: Fabian Nietlispach June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Snapshot #2: Economic Benefits With a Minimalist TAVR Strategy Are Indisputable! Presenter: Hemal Gada June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Snapshot #1: Preserving TEE is Fundamental Results From a High-Volume Minimalist TAVR Center Presenter: Philippe Genereux June 22, 2018
Presentation The Structural Heart Disease Summit 2018 The Voice of Interventional Echocardiography: Situations where TEE Provides Meaningful Value During TAVR (With Convincing Case Examples) Presenter: Vinod H. Thourani, John G. Webb, Rebecca T. Hahn June 22, 2018
Presentation The Structural Heart Disease Summit 2018 The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK Presenter: Vinod H. Thourani, John G. Webb, David A. Wood June 22, 2018
Presentation The Structural Heart Disease Summit 2018 The Minimalist TAVR Strategy Should be the Default Approach Supported by Clinical Outcomes and Economic Benefits Presenter: Vinod H. Thourani, John G. Webb June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends Presenter: Michael J. Mack, Raj Makkar June 22, 2018
Presentation The Structural Heart Disease Summit 2018 New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS June 22, 2018
Presentation The Structural Heart Disease Summit 2018 The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies Presenter: Michael J. Mack, Raj Makkar, Lars Sondergaard June 22, 2018
Presentation The Structural Heart Disease Summit 2018 TAVR to Treat Pure Aortic Regurgitation: Published and Personal Experiences (With Case Examples) Presenter: Howard C. Herrmann, Allan Schwartz, Eberhard Grube June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset Presenter: Howard C. Herrmann, Allan Schwartz, Jonathan Afilalo June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Who Shouldnt Undergo TAVR? Can We Identify the Futile Non-responders? Presenter: Howard C. Herrmann, Allan Schwartz, Suzanne V. Arnold June 22, 2018
Presentation The Structural Heart Disease Summit 2018 CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS Presenter: Howard C. Herrmann, Allan Schwartz June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction Presenter: Howard C. Herrmann, Allan Schwartz, Nicolas M. Van Mieghem June 22, 2018